SCHEMBL24536826

SCHEMBL24536826

CCc1c(F)ccc2cc(O)cc(-c3ncc4c(OCC(F)(F)F)nc(OCC5(CN(C)C)CC5)nc4c3F)c12

nearest known ligand 0.52

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
▸ KRAS P01116 20/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29680489 1.00 KRAS (0.52) KRAS
SCHEMBL25335948 0.91 KRAS (0.43) KRAS
SCHEMBL25335716 0.89 KRAS (0.50) KRAS
SCHEMBL29679897 0.88 KRAS (0.55) KRAS
SCHEMBL24536723 0.85 KRAS (0.70) KRAS
SCHEMBL29680343 0.85 KRAS (0.70) KRAS
SCHEMBL24535674 0.85 KRAS (0.48) KRAS
SCHEMBL27394644 0.85 KRAS (0.51) KRAS
SCHEMBL27394751 0.84 KRAS (0.63) KRAS
SCHEMBL27394760 0.84 KRAS (0.61) KRAS

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022132200-A1 AZAQUINAZOLINE PAN-KRAS INHIBITORS Mirati Therapeutics, Inc. (US) 2022-06-23 — — WO disclosed
Send feedback